Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume 49, Issue 7, Pages 865-872
Publisher
Springer Nature
Online
2014-03-31
DOI
10.1038/bmt.2014.39
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-Effectiveness Analysis of a Risk-Adapted Algorithm of Plerixafor Use for Autologous Peripheral Blood Stem Cell Mobilization
- (2012) Ivana N.M. Micallef et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The EBMT activity survey: 1990–2010
- (2012) J R Passweg et al. BONE MARROW TRANSPLANTATION
- Growth factor plus preemptive (‘just-in-time’) plerixafor successfully mobilizes hematopoietic stem cells in multiple myeloma patients despite prior lenalidomide exposure
- (2012) L J Costa et al. BONE MARROW TRANSPLANTATION
- Clinical experience with a simple algorithm for plerixafor utilization in autologous stem cell mobilization
- (2012) A I Chen et al. BONE MARROW TRANSPLANTATION
- Predictive factors for poor peripheral blood stem cell mobilization and peak CD34+cell count to guide pre-emptive or immediate rescue mobilization.
- (2012) Juan-Manuel Sancho et al. CYTOTHERAPY
- Predictive factors for inadequate stem cell mobilization in Chinese patients with NHL and HL: 14-year experience of a single-center study
- (2012) Xiaohong Han et al. JOURNAL OF CLINICAL APHERESIS
- CD34+ cell subclasses and lymphocyte subsets in blood grafts collected after various mobilization methods in myeloma patients
- (2012) Ville Varmavuo et al. TRANSFUSION
- Blood graft lymphocyte subsets after plerixafor injection in non-Hodgkin's lymphoma patients mobilizing poorly with chemotherapy plus granulocyte-colony-stimulating factor
- (2012) Ville Varmavuo et al. TRANSFUSION
- Hematopoietic recovery kinetics predicts for poor CD34+ cell mobilization after cyclophosphamide chemotherapy in multiple myeloma
- (2011) Guner Hayri Ozsan et al. AMERICAN JOURNAL OF HEMATOLOGY
- Plerixafor Added to Chemotherapy Plus G-CSF Is Safe and Allows Adequate PBSC Collection in Predicted Poor Mobilizer Patients with Multiple Myeloma or Lymphoma
- (2011) Immacolata Attolico et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation
- (2011) J Waterman et al. BONE MARROW TRANSPLANTATION
- A risk-based approach to optimize autologous hematopoietic stem cell (HSC) collection with the use of plerixafor
- (2011) S Abhyankar et al. BONE MARROW TRANSPLANTATION
- Proposed definition of ‘poor mobilizer’ in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo
- (2011) A Olivieri et al. BONE MARROW TRANSPLANTATION
- ISHAGE protocol: Are we doing it correctly?
- (2011) Alison Whitby et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Haematopoietic stem cell mobilization with plerixafor and G-CSF in patients with multiple myeloma transplanted with autologous stem cells
- (2011) Grzegorz W. Basak et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- In and out of the niche: perspectives in mobilization of hematopoietic stem cells
- (2011) Mohamad Mohty et al. EXPERIMENTAL HEMATOLOGY
- Novel strategies for blood stem cell mobilization: special focus on plerixafor
- (2011) Esa Jantunen EXPERT OPINION ON BIOLOGICAL THERAPY
- Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy
- (2011) F Cavallo et al. LEUKEMIA
- Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies
- (2011) S Sinha et al. LEUKEMIA
- Plerixafor to rescue failing chemotherapy-based stem cell mobilization: it’s not too late
- (2011) Grzegorz W. Basak et al. LEUKEMIA & LYMPHOMA
- Preemptive use of plerixafor in difficult-to-mobilize patients: an emerging concept
- (2011) Esa Jantunen et al. TRANSFUSION
- Hematopoietic stem cells from poor and good mobilizers are qualitatively equivalent
- (2011) Liuyan Jiang et al. TRANSFUSION
- Chemomobilization with Etoposide is Highly Effective in Patients with Multiple Myeloma and Overcomes the Effects of Age and Prior Therapy
- (2010) William A. Wood et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Relevance and Clinical Implications of Tumor Cell Mobilization in the Autologous Transplant Setting
- (2010) John F. DiPersio et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Optimal timing of G-CSF administration for effective autologous stem cell collection
- (2010) J E Kim et al. BONE MARROW TRANSPLANTATION
- Growth factor and patient-adapted use of plerixafor is superior to CY and growth factor for autologous hematopoietic stem cells mobilization
- (2010) L J Costa et al. BONE MARROW TRANSPLANTATION
- Stem cell collection in patients with multiple myeloma: impact of induction therapy and mobilization regimen
- (2010) A Nazha et al. BONE MARROW TRANSPLANTATION
- Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftment
- (2010) H E Johnsen et al. BONE MARROW TRANSPLANTATION
- Ancestim (r-metHuSCF) plus filgrastim and/or chemotherapy for mobilization of blood progenitors in 513 poorly mobilizing cancer patients: the French compassionate experience
- (2010) V Lapierre et al. BONE MARROW TRANSPLANTATION
- The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF
- (2010) A D'Addio et al. BONE MARROW TRANSPLANTATION
- Development and validation of a decision-making algorithm to guide the use of plerixafor for autologous hematopoietic stem cell mobilization
- (2010) L J Costa et al. BONE MARROW TRANSPLANTATION
- Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention
- (2010) S Sinha et al. BONE MARROW TRANSPLANTATION
- Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data
- (2010) R F Duarte et al. BONE MARROW TRANSPLANTATION
- review: Current status of stem cell mobilization
- (2010) Morie A. Gertz BRITISH JOURNAL OF HAEMATOLOGY
- A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study
- (2010) Stefan Fruehauf et al. CYTOTHERAPY
- Characterization of hematopoietic stem cell subsets from patients with multiple myeloma after mobilization with plerixafor
- (2010) Isabel Taubert et al. CYTOTHERAPY
- Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization
- (2010) Azzurra Romeo et al. TRANSFUSION
- Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma
- (2009) Hideki Nakasone et al. AMERICAN JOURNAL OF HEMATOLOGY
- Single-dose pegfilgrastim is comparable to daily filgrastim in mobilizing peripheral blood stem cells: a case-matched study in patients with lymphoproliferative malignancies
- (2009) Mervi Putkonen et al. ANNALS OF HEMATOLOGY
- Successful Stem Cell Remobilization Using Plerixafor (Mozobil) Plus Granulocyte Colony-Stimulating Factor in Patients with Non-Hodgkin Lymphoma: Results from the Plerixafor NHL Phase 3 Study Rescue Protocol
- (2009) Ivana N. Micallef et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Impairment of Filgrastim-Induced Stem Cell Mobilization after Prior Lenalidomide in Patients with Multiple Myeloma
- (2009) Uday Popat et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Poor Mobilization of Hematopoietic Stem Cells—Definitions, Incidence, Risk Factors, and Impact on Outcome of Autologous Transplantation
- (2009) Patrick Wuchter et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Improving stem cell mobilization strategies: future directions
- (2009) W Bensinger et al. BONE MARROW TRANSPLANTATION
- Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patients
- (2009) S Fruehauf et al. BONE MARROW TRANSPLANTATION
- Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization
- (2009) M J Dugan et al. BONE MARROW TRANSPLANTATION
- Safety and efficacy assessment of plerixafor in patients with multiple myeloma proven or predicted to be poor mobilizers, including assessment of tumor cell mobilization
- (2009) G Tricot et al. BONE MARROW TRANSPLANTATION
- Efficacious but insidious: A retrospective analysis of fludarabine-induced myelotoxicity using long-term culture–initiating cells in 100 follicular lymphoma patients
- (2009) Andrea Janikova et al. EXPERIMENTAL HEMATOLOGY
- Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma
- (2009) John F. DiPersio et al. JOURNAL OF CLINICAL ONCOLOGY
- Impairment of peripheral blood stem-cell mobilisation in patients with mantle-cell lymphoma following primary treatment with fludarabine and cyclophosphamide±rituximab
- (2009) Heather E. Eve et al. LEUKEMIA & LYMPHOMA
- Management of poor peripheral blood stem cell mobilization: Incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian institutions
- (2009) Paolo Perseghin et al. TRANSFUSION AND APHERESIS SCIENCE
- Stem Cell Mobilization with Cyclophosphamide Overcomes the Suppressive Effect of Lenalidomide Therapy on Stem Cell Collection in Multiple Myeloma
- (2008) Tomer Mark et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Comparison of Twin and Autologous Transplants for Multiple Myeloma
- (2008) Asad Bashey et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous Transplantation
- (2008) Iskra Pusic et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A Phase II Study of Plerixafor (AMD3100) plus G-CSF for Autologous Hematopoietic Progenitor Cell Mobilization in Patients with Hodgkin Lymphoma
- (2008) Amanda Cashen et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- EPO in combination with G-CSF improves mobilization effectiveness after chemotherapy with ifosfamide, epirubicin and etoposide and reduces costs during mobilization and transplantation of autologous hematopoietic progenitor cells
- (2008) C Hart et al. BONE MARROW TRANSPLANTATION
- A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma
- (2008) E Copelan et al. BONE MARROW TRANSPLANTATION
- Contaminating tumour cells in autologous PBSC grafts do not influence survival or relapse following transplant for multiple myeloma or B-cell non-Hodgkin's lymphoma
- (2008) J Ho et al. BONE MARROW TRANSPLANTATION
- Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma
- (2008) M A Gertz et al. BONE MARROW TRANSPLANTATION
- IVE (ifosfamide, epirubicin and etoposide) is a more effective stem cell mobilisation regimen than ICE (ifosphamide, carboplatin and etoposide) in the context of salvage therapy for lymphoma
- (2008) C. P. Fox et al. BRITISH JOURNAL OF HAEMATOLOGY
- The Use of Growth Factors in Hematopoietic Stem Cell Transplantation
- (2008) I. Pusic et al. CURRENT PHARMACEUTICAL DESIGN
- A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy
- (2008) N. Russell et al. HAEMATOLOGICA
- Mobilization of peripheral blood stem cells in myeloma with either pegfilgrastim or filgrastim following chemotherapy
- (2008) G. Tricot et al. HAEMATOLOGICA
- Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma
- (2008) H. G. Kopp et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma
- (2008) H Paripati et al. LEUKEMIA
- Factors affecting hematopoietic progenitor cell mobilization: An analysis of 307 patients
- (2008) Alfredo Mendrone et al. TRANSFUSION AND APHERESIS SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started